These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33999349)

  • 1. Pituitary Adenylate Cyclase-Activating Polypeptide Protects Against Cognitive Impairment Caused by Chronic Cerebral Hypoperfusion.
    Guo X; Tian Y; Yang Y; Li S; Guo L; Shi J
    Mol Neurobiol; 2021 Sep; 58(9):4309-4322. PubMed ID: 33999349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington's Disease.
    Cabezas-Llobet N; Vidal-Sancho L; Masana M; Fournier A; Alberch J; Vaudry D; Xifró X
    Mol Neurobiol; 2018 Nov; 55(11):8263-8277. PubMed ID: 29526016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PACAP enhances axon outgrowth in cultured hippocampal neurons to a comparable extent as BDNF.
    Ogata K; Shintani N; Hayata-Takano A; Kamo T; Higashi S; Seiriki K; Momosaki H; Vaudry D; Vaudry H; Galas L; Kasai A; Nagayasu K; Nakazawa T; Hashimoto R; Ago Y; Matsuda T; Baba A; Hashimoto H
    PLoS One; 2015; 10(3):e0120526. PubMed ID: 25807538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary adenylate cyclase-activating polypeptide protects against β-amyloid toxicity.
    Han P; Tang Z; Yin J; Maalouf M; Beach TG; Reiman EM; Shi J
    Neurobiol Aging; 2014 Sep; 35(9):2064-71. PubMed ID: 24726470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors in the mechanism of antidepressant action.
    Reichenstein M; Rehavi M; Pinhasov A
    J Mol Neurosci; 2008 Nov; 36(1-3):330-8. PubMed ID: 18592413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary adenylate cyclase-activating polypeptide is up-regulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic/ischemic damage.
    Stumm R; Kolodziej A; Prinz V; Endres M; Wu DF; Höllt V
    J Neurochem; 2007 Nov; 103(4):1666-81. PubMed ID: 17868305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDACi protects against vascular cognitive impairment from CCH injury via induction of BDNF-related AMPA receptor activation.
    Fang YC; Hsieh JY; Vidyanti AN; Yang CH; Jan JS; Chang KW; Hu CJ; Tu YK
    J Cell Mol Med; 2021 Aug; 25(15):7418-7425. PubMed ID: 34216182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior.
    Hammack SE; Cheung J; Rhodes KM; Schutz KC; Falls WA; Braas KM; May V
    Psychoneuroendocrinology; 2009 Jul; 34(6):833-43. PubMed ID: 19181454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus.
    Costa L; Santangelo F; Li Volsi G; Ciranna L
    Hippocampus; 2009 Jan; 19(1):99-109. PubMed ID: 18727050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cyclic AMP effects and neuroprotective activities of PACAP and VIP in cultured astrocytes and neurons exposed to oxygen-glucose deprivation.
    Jóźwiak-Bębenista M; Kowalczyk E; Nowak JZ
    Pharmacol Rep; 2015 Apr; 67(2):332-8. PubMed ID: 25712659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary Adenylate Cyclase Activating Polypeptide Elicits Neuroprotection Against Acute Ischemic Neuronal Cell Death Associated with NMDA Receptors.
    Kaneko Y; Tuazon JP; Ji X; Borlongan CV
    Cell Physiol Biochem; 2018; 51(4):1982-1995. PubMed ID: 30513524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary adenylate cyclase activating polypeptide and PAC1 receptor signaling increase Homer 1a expression in central and peripheral neurons.
    Girard BM; Keller ET; Schutz KC; May V; Braas KM
    Regul Pept; 2004 Dec; 123(1-3):107-16. PubMed ID: 15518900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence and distribution of pituitary adenylate cyclase activating polypeptide and its receptor in the snail Helix pomatia.
    Hernádi L; Pirger Z; Kiss T; Németh J; Mark L; Kiss P; Tamas A; Lubics A; Toth G; Shioda S; Reglodi D
    Neuroscience; 2008 Aug; 155(2):387-402. PubMed ID: 18590802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of PACAP in ischemia.
    Reglodi D; Vaczy A; Rubio-Beltran E; MaassenVanDenBrink A
    J Headache Pain; 2018 Mar; 19(1):19. PubMed ID: 29500688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Obesity on Cognitive Impairment in Vascular Dementia Rat Model via BDNF-ERK-CREB Pathway.
    Kim Y; Kim YJ
    Biol Res Nurs; 2021 Apr; 23(2):248-257. PubMed ID: 32844660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pivotal role of pituitary adenylate cyclase-activating polypeptide for lactate production and secretion in astrocytes during fear memory.
    Kambe Y; Yamauchi Y; Thanh Nguyen T; Thi Nguyen T; Ago Y; Shintani N; Hashimoto H; Yoshitake S; Yoshitake T; Kehr J; Kawamura N; Katsuura G; Kurihara T; Miyata A
    Pharmacol Rep; 2021 Aug; 73(4):1109-1121. PubMed ID: 33835466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BDNF mediates the neuroprotective effect of PACAP-38 on rat cortical neurons.
    Frechilla D; García-Osta A; Palacios S; Cenarruzabeitia E; Del Rio J
    Neuroreport; 2001 Apr; 12(5):919-23. PubMed ID: 11303760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro- and anti-mitogenic actions of pituitary adenylate cyclase-activating polypeptide in developing cerebral cortex: potential mediation by developmental switch of PAC1 receptor mRNA isoforms.
    Yan Y; Zhou X; Pan Z; Ma J; Waschek JA; DiCicco-Bloom E
    J Neurosci; 2013 Feb; 33(9):3865-78. PubMed ID: 23447598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrolysin alleviates cognitive deficits induced by chronic cerebral hypoperfusion by increasing the levels of plasticity-related proteins and decreasing the levels of apoptosis-related proteins in the rat hippocampus.
    Liu Z; Hu M; Lu P; Wang H; Qi Q; Xu J; Xiao Y; Fan M; Jia Y; Zhang D
    Neurosci Lett; 2017 Jun; 651():72-78. PubMed ID: 28458021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenylate cyclase-activating polypeptide regulates brain-derived neurotrophic factor exon IV expression through the VPAC1 receptor in the amphibian melanotrope cell.
    Kidane AH; Roubos EW; Jenks BG
    Endocrinology; 2008 Aug; 149(8):4177-82. PubMed ID: 18450956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.